Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -A$80.46 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$77.62 Million a decrease over its 2023 earnings that were of -A$67.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$80.46 Million3.66%
2024 -A$77.62 Million14.77%
2023 -A$67.63 Million-17.49%
2022 -A$81.97 Million22.96%
2021 -A$66.66 Million35.36%
2020 -A$49.25 Million12.65%
2019 -A$43.72 Million29.09%
2018 -A$33.87 Million36.33%
2017 -A$24.84 Million17.11%
2016 -A$21.21 Million20.91%
2015 -A$17.55 Million-6.29%
2014 -A$18.72 Million337.28%
2013 -A$4.29 Million
2008 -A$7.92 Million106.01%
2007 -A$3.85 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.10 B-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.97 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$98.71 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$26.04 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA